Si prevede che il mercato degli agenti di mezzi di contrasto raggiungerà 8.391,1 milioni di dollari entro il 2028 da 5.599,6 dollari milioni nel 2022; si prevede che crescerà a un CAGR del 7,0% dal 2022 al 2028.
Gli agenti di contrasto sono sostanze utilizzate per aumentare la radiodensità di un tessuto interessato alterando il modo di passaggio delle onde ultrasoniche o delle radiazioni elettromagnetiche attraverso il corpo. Queste sostanze possono essere somministrate per via rettale, orale o endovenosa. La scelta del tipo di mezzo di contrasto dipende dalla modalità e dallo scopo dell'imaging. La crescente prevalenza di malattie croniche, il crescente numero di approvazioni per agenti di contrasto e gli sviluppi nelle modalità di imaging diagnostico sono tra i fattori chiave che contribuiscono alla crescita del mercato. Tuttavia, gli effetti collaterali dei mezzi di contrasto ne ostacolano l'uso.
Il Il mercato degli agenti di contrasto media è segmentato in base la base del tipo, della mobilità delle immagini, dell'indicazione, della via di somministrazione e della geografia. Il rapporto offre approfondimenti e analisi approfondite del mercato, sottolineando parametri quali tendenze di mercato, progressi tecnologici, dinamiche di mercato e analisi del panorama competitivo (dei principali attori del mercato).
Approfondimenti strategici
Regioni redditizie per il mercato degli agenti di contrasto
Approfondimenti di mercato
< h3>L'aumento dell'incidenza e della prevalenza delle malattie croniche stimola la crescita del mercato
Le malattie croniche cardiovascolari, respiratorie e ortopediche e vari tipi di cancro stanno causando disabilità e mortalità in tutto il mondo. Queste condizioni cliniche influenzano la qualità complessiva della vita. Secondo l’Organizzazione Mondiale della Sanità (OMS), si stima che circa il 50% della popolazione mondiale soffra di almeno una malattia cronica. I Centri per il controllo e la prevenzione delle malattie (CDC) hanno affermato che 6 persone su 10 negli Stati Uniti soffrivano di almeno una malattia cronica nel 2019. Le malattie cardiovascolari (CVD) sono una causa significativa di mortalità a livello globale. Secondo l’American Heart Association, negli Stati Uniti l’incidenza dell’insufficienza cardiaca è in aumento. Nel 2019, circa 874.613 persone sono morte a causa di malattie cardiovascolari negli Stati Uniti. Secondo un articolo pubblicato da Single Care, nel 2021 oltre 350 milioni di persone nel mondo convivevano con l’artrite. Stati Uniti, Giappone, Corea del Sud, Canada, Regno Unito, Spagna e Francia (insieme a Cina, India, Arabia Saudita, Emirati Arabi Uniti e Brasile) stanno assistendo a una crescita sostanziale della popolazione geriatrica, che corre un rischio maggiore di artrite. Pertanto, la crescente prevalenza di patologie croniche crea la necessità di sistemi diagnostici sicuri, efficaci ed efficienti, come raggi X/TC, risonanza magnetica e ultrasuoni, che, a loro volta, stanno guidando la crescita del mercato globale degli agenti di contrasto.
< h3>Percorso di approfondimenti basati sull'amministrazione
In base alla via di somministrazione, il mercato degli agenti di contrasto è segmentato in intravascolare, orale e rettale. Il segmento intravascolare deteneva la quota di mercato maggiore nel 2022 e si prevede che registrerà il CAGR più elevato durante il periodo di previsione. La crescita del mercato di questo segmento è attribuita all'ampio utilizzo di iniezioni di mezzi di contrasto grazie alla loro capacità di fornire sostanze a qualsiasi parte del corpo.
Approfondimenti basati sulla modalità di imaging
In base alla modalità di imaging, il mercato degli agenti di contrasto è segmentato in raggi X/TC, risonanza magnetica e ultrasuoni. Il segmento dei raggi X/TC ha rappresentato la quota di mercato maggiore nel 2022. Tuttavia, si prevede che il segmento degli ultrasuoni registrerà il CAGR più elevato nel periodo 2022-2028.
Il Nord America detiene una quota importante del mercato degli agenti di contrasto e si prevede che mostri una tendenza simile durante il periodo di previsione. Gli Stati Uniti sono il maggior consumatore di mezzi di contrasto in questa regione. Negli Stati Uniti è stato approvato il primo mezzo di contrasto a base di gadolinio. Inoltre, altri quattro agenti hanno ricevuto l’approvazione della FDA negli Stati Uniti negli ultimi dieci anni, indicando una forte inclinazione verso l’introduzione di agenti più efficienti, sicuri e accurati nel paese. Inoltre, l’aumento dell’incidenza di malattie croniche, come le malattie neurologiche e cardiovascolari, è il principale fattore che guida la crescita del mercato degli agenti di contrasto negli Stati Uniti. La richiesta di mezzi di contrasto è considerevolmente elevata nelle tecniche ecografiche tra tutte le modalità di imaging.
Il mercato degli agenti di mezzi di contrasto è segmentato in base alla tipologia , modalità di imaging, indicazione, via di somministrazione e geografia. In base alla tipologia, il mercato è segmentato in mezzi di contrasto iodati, mezzi di contrasto a base di gadolinio, mezzi di contrasto a base di bario e mezzi di contrasto a microbolle. In termini di modalità di imaging, il mercato è suddiviso in raggi X/TC, risonanza magnetica e ultrasuoni. In base alle indicazioni, il mercato è segmentato in disturbi cardiovascolari, cancro, disturbi gastrointestinali, disturbi muscoloscheletrici, disturbi neurologici e disturbi nefrologici. Il mercato dei mezzi di contrasto, in base alla via di somministrazione, è segmentato in intravascolare, orale e rettale. In base alla geografia, il mercato è segmentato in Nord America (Stati Uniti, Canada e Messico), Europa (Regno Unito, Germania, Francia, Italia, Spagna e resto d’Europa), Asia Pacifico (Cina, Giappone, India, Corea del Sud , Australia e resto dell'Asia Pacifico), Medio Oriente e Stati Uniti. Africa (Emirati Arabi Uniti, Arabia Saudita, Sud Africa e resto del Medio Oriente e dell'Africa) e Sud e Africa. America centrale (Brasile, Argentina e resto dell'America meridionale e centrale).
Profili aziendali
- General Electric
- Bayer AG
- Bracco
- Guerbet
- Lantheus Medical Imaging Inc< /span>
- nanoPET Pharma GmbH
- Unijules Life Science Ltd
- Magnus Health Management Pvt Ltd
- JB Chemical and Pharmaceuticals Ltd
- Jodan Expoim
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. General Electric
2. Bayer AG
3. Bracco
4. GUERBET
5. Lantheus Medical Imaging, Inc.
6. nanoPET Pharma GmbH
7. Unijules Life Sciences Ltd.
8. Magnus Health Management Pvt Ltd.
9. J.B.Chemicals and Pharmaceuticals Ltd.
10. Jodas Expoim
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)